MANILA, Philippines — A total of 37 Covid-19 patients have enrolled in the clinical trials for Japan’s anti-influenza drug Avigan as a cure against the cardiovascular and respiratory disease, the Department of Health (DOH) said Monday.
“As to the Avigan trial, last January 28, we have a total of 37 patients enrolled in the trial,” Health undersecretary Maria Rosario Vergeire said in an online press briefing.
Of the 37 patients, 25 have completed their medication, six are being treated, and four have withdrawn, according to Vergeire. She added the clinical trials being conducted on two other patients was stopped but did not provide further details.
Avigan, the Japanese brand fo…
Keep on reading: 37 coronavirus patients enrolled in Avigan trials